Correlation Between Merck and 63254ABG2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Merck Company and NAB 5132 22 NOV 24, you can compare the effects of market volatilities on Merck and 63254ABG2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of 63254ABG2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and 63254ABG2.
Diversification Opportunities for Merck and 63254ABG2
Excellent diversification
The 3 months correlation between Merck and 63254ABG2 is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and NAB 5132 22 NOV 24 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAB 5132 22 and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with 63254ABG2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAB 5132 22 has no effect on the direction of Merck i.e., Merck and 63254ABG2 go up and down completely randomly.
Pair Corralation between Merck and 63254ABG2
Considering the 90-day investment horizon Merck Company is expected to under-perform the 63254ABG2. In addition to that, Merck is 7.89 times more volatile than NAB 5132 22 NOV 24. It trades about -0.18 of its total potential returns per unit of risk. NAB 5132 22 NOV 24 is currently generating about 0.17 per unit of volatility. If you would invest 10,009 in NAB 5132 22 NOV 24 on September 21, 2024 and sell it today you would earn a total of 68.00 from holding NAB 5132 22 NOV 24 or generate 0.68% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 41.27% |
Values | Daily Returns |
Merck Company vs. NAB 5132 22 NOV 24
Performance |
Timeline |
Merck Company |
NAB 5132 22 |
Merck and 63254ABG2 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and 63254ABG2
The main advantage of trading using opposite Merck and 63254ABG2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, 63254ABG2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 63254ABG2 will offset losses from the drop in 63254ABG2's long position.Merck vs. Emergent Biosolutions | Merck vs. Neurocrine Biosciences | Merck vs. Teva Pharma Industries | Merck vs. Haleon plc |
63254ABG2 vs. Nok Airlines Public | 63254ABG2 vs. Osaka Steel Co, | 63254ABG2 vs. Sun Country Airlines | 63254ABG2 vs. flyExclusive, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |